This episode of “The Readout LOUD,” STAT’s biotech podcast, covers a range of topics including what makes a blockbuster drug, the implications of Aduhelm for biotech, and the retirement of a significant FDA figure. They also discuss Vertex Pharmaceuticals’ novel pain drug and its success in clinical trials. The episode offers more information on these topics and how to stay updated on biotech news. It is available on various podcast platforms and feedback can be sent via email. Additionally, there is a Facebook pixel for tracking events related to the podcast.
Source link
Vertex data, Aduhelm, & Woodcock retires
